These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4040 related items for PubMed ID: 14615693

  • 1. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S, Ferreri M, Cabanac F, Bitton M.
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [Abstract] [Full Text] [Related]

  • 2. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS, Benazzi F, Perugi G, Rihmer Z.
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [Abstract] [Full Text] [Related]

  • 3. [Residual symptoms after a treated major depressive disorder: a survey among private psychiatrists].
    Mouchabac S, Ferreri M, Cabanac F, Bitton M.
    Encephale; 2003 Apr; 29(4 Pt 1):306-12. PubMed ID: 14615700
    [Abstract] [Full Text] [Related]

  • 4. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 5. Residual anxiety symptoms in depressed primary care patients.
    McIntyre RS, Konarski JZ, Soczynska JK, Kennedy SH.
    J Psychiatr Pract; 2007 Mar; 13(2):125-8. PubMed ID: 17414691
    [Abstract] [Full Text] [Related]

  • 6. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
    Vieta E, Sánchez-Moreno J, Lahuerta J, Zaragoza S, EDHIPO Group (Hypomania Detection Study Group).
    J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
    [Abstract] [Full Text] [Related]

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.
    Encephale; 2003 Apr; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [Abstract] [Full Text] [Related]

  • 8. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [Abstract] [Full Text] [Related]

  • 9. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P, Lönn SL, Overø KF.
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [Abstract] [Full Text] [Related]

  • 10. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F, Martin-Guehl C, Maurice-Tison S, Bouvard MP.
    Encephale; 2003 Feb; 29(5):391-400. PubMed ID: 14615688
    [Abstract] [Full Text] [Related]

  • 11. Objective: remission of depression in primary care The Oreon Study.
    Ansseau M, Demyttenaere K, Heyrman J, Migeotte A, Leyman S, Mignon A.
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):169-76. PubMed ID: 19144502
    [Abstract] [Full Text] [Related]

  • 12. [Antidepressants consumption in the global population in France].
    Olié JP, Elomari F, Spadone C, Lépine JP.
    Encephale; 2002 Mar; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [Abstract] [Full Text] [Related]

  • 13. Time course of depression-symptom improvement during treatment with duloxetine.
    Hirschfeld RM, Mallinckrodt C, Lee TC, Detke MJ.
    Depress Anxiety; 2005 Mar; 21(4):170-7. PubMed ID: 16035056
    [Abstract] [Full Text] [Related]

  • 14. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
    Akiskal HS, Benazzi F.
    J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
    [Abstract] [Full Text] [Related]

  • 15. Power laws in covariability of anxiety and depression among newly diagnosed patients with major depressive episode, panic disorder and controls.
    Katerndahl DA.
    J Eval Clin Pract; 2009 Jun; 15(3):565-70. PubMed ID: 19522912
    [Abstract] [Full Text] [Related]

  • 16. [Depressive symptomatology and sleep apnea syndrome].
    Pochat MD, Ferber C, Lemoine P.
    Encephale; 1993 Jun; 19(6):601-7. PubMed ID: 12404778
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 18. A tetrachoric factor analysis validation of mixed depression.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):186-92. PubMed ID: 17804137
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
    Daléry J, Aubin V.
    Encephale; 2001 Jan 01; 27(1):71-81. PubMed ID: 11294041
    [Abstract] [Full Text] [Related]

  • 20. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U, Onder E.
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec 01; 253(6):307-12. PubMed ID: 14714120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 202.